Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Rebecca Hein(Technical University of Munich), Nazneen Rahman(Institute of Cancer Research), Volker Arndt(German Cancer Research Center), Marjanka K. Schmidt(University of Cambridge), Christina A. Clarke(Menlo School), Julian Peto(London School of Hygiene & Tropical Medicine), Peter A. Fasching(Universitätsklinikum Erlangen), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Annegien Broeks, Kenneth Muir(Manchester Academic Health Science Centre), F. Ménégaux(Université Paris-Sud), Ian Tomlinson(University of Oxford), Roger L. Milne(The University of Melbourne), Miroslaw K. Kapuscinski(The University of Melbourne), Arif B. Ekici(University Medical Center Groningen), Leslie Bernstein(National Cancer Institute), H. Bas Bueno-de-Mesquit(National Institute for Public Health and the Environment), Melanie Maranian(University of Cambridge), Daniel J. Park(The University of Melbourne), Frederick Marmee(Heidelberg University), José Ignacio Arias Pérez, Elinor J. Sawyer(King's College London), Olivia Fletcher(Breast Cancer Care), Argyrios Ziogas(University of Copenhagen), Stig E. Bojesen(University of Copenhagen), M. Pilar Zamora(Universidad Autónoma de Madrid), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Børge G. Nordestgaard(Gentofte Hospital), Javier BenÃtez(Spanish National Cancer Research Centre), Christof Sohn, Heiko Mà ⁄ ller(German Cancer Research Center), Puttisak Puttawibul(Prince of Songkla University), Alexander Hein, Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Pascal Guénel(Université Paris-Sud), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, Christa Stegmaier(Karolinska University Hospital), Frans B.L. Hogervorst(The Netherlands Cancer Institute), Emilie Cordina‐Duverger(Mayo Clinic), John L. Hopper(The University of Melbourne), Artitaya Lophatananon(University of Warwick), Suthee Rattanamongkongul(Srinakharinwirot University), Henrik Flyger(Herlev Hospital), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Nicola Miller(Ollscoil na Gaillimhe – University of Galway), Nichola Johnson(Institute of Cancer Research)
Cited by 4
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k